The transmembrane domain of CEACAM1-4S is a determinant of anchorage independent growth and tumorigenicity

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Lawson, Erica L ^a   Mills, David R ^a   Brilliant, Kate E ^a   Hixson, Douglas C ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1-4S; GLYCINE; LEUCINE; TYROSINE; UNCLASSIFIED DRUG; VALINE; CD66 ANTIGENS; CELL ADHESION MOLECULE; ISOPROTEIN; LEUKOCYTE ANTIGEN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; DIMERIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN DOMAIN; RAT; SITE DIRECTED MUTAGENESIS; TRANSMEMBRANE DOMAIN; AMINO ACID SEQUENCE; ANIMAL; CELL MEMBRANE; CELL SIZE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; MUTATION; PATHOLOGY; PHENOTYPE; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; TUMOR CELL LINE;

RATTUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CELL SIZE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PHENOTYPE; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RATS; TRANSFECTION; TYROSINE;

EID: 84855301767     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029606     Document Type: Article

References (60)

1. Lin SH, Culic O, Flanagan D, Hixson DC, (1991) Immunochemical characterization of two isoforms of rat liver ecto-ATPase that show an immunological and structural identity with a glycoprotein cell-adhesion molecule with Mr 105,000. Biochem J 278 (Pt 1): 155-161.
2. Culic O, Huang QH, Flanagan D, Hixson D, Lin SH, (1992) Molecular cloning and expression of a new rat liver cell-CAM105 isoform. Differential phosphorylation of isoforms. Biochem J 285 (Pt 1): 47-53.
3. McEntire KD, Mowery J, Hixson DC, (1989) Comparison of the structural characteristics of cell-CAM 105 from hepatocytes with those of an altered form expressed by rat transplantable hepatocellular carcinomas. Cancer Res 49: 6795-6802.
4. Edlund M, Gaardsvoll H, Bock E, Obrink B, (1993) Different isoforms and stock-specific variants of the cell adhesion molecule C-CAM (cell-CAM 105) in rat liver. Eur J Biochem 213: 1109-1116.
5. Lin SH, Guidotti G, (1989) Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. The primary structure of the ecto-ATPase is similar to that of the human biliary glycoprotein I. J Biol Chem 264: 14408-14414.
6. Hixson DC, McEntire KD, Obrink B, (1985) Alterations in the expression of a hepatocyte cell adhesion molecule by transplantable rat hepatocellular carcinomas. Cancer Res 45: 3742-3749.
7. Hixson DC, McEntire KD, (1989) Detection of an altered form of cell-CAM 105 on rat transplantable and primary hepatocellular carcinomas. Cancer Res 49: 6788-6794.
8. Tanaka K, Hinoda Y, Takahashi H, Sakamoto H, Nakajima Y, et al. (1997) Decreased expression of biliary glycoprotein in hepatocellular carcinomas. Int J Cancer 74: 15-19.
9. Neumaier M, Paululat S, Chan A, Matthaes P, Wagener C, (1993) Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci U S A 90: 10744-10748.
10. Kleinerman DI, Zhang WW, Lin SH, Nguyen TV, von Eschenbach AC, et al. (1995) Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study. Cancer Res 55: 2831-2836.
11. Riethdorf L, Lisboa BW, Henkel U, Naumann M, Wagener C, et al. (1997) Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J Histochem Cytochem 45: 957-963.
12. Oliveira-Ferrer L, Tilki D, Ziegeler G, Hauschild J, Loges S, et al. (2004) Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. Cancer Res 64: 8932-8938.
13. Laurie NA, Comegys MM, Carreiro MP, Brown JF, Flanagan DL, et al. (2005) Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas. Cancer Res 65: 11010-11017.
14. Estrera VT, Luo W, Phan D, Earley K, Hixson DC, et al. (1999) The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells. Biochem Biophys Res Commun 263: 797-803.
15. Izzi L, Turbide C, Houde C, Kunath T, Beauchemin N, (1999) cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 18: 5563-5572.
16. Estrera VT, Chen DT, Luo W, Hixson DC, Lin SH, (2001) Signal transduction by the CEACAM1 tumor suppressor. Phosphorylation of serine 503 is required for growth-inhibitory activity. J Biol Chem 276: 15547-15553.
17. Kunath T, Ordonez-Garcia C, Turbide C, Beauchemin N, (1995) Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene 11: 2375-2382.
18. Turbide C, Kunath T, Daniels E, Beauchemin N, (1997) Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth. Cancer Res 57: 2781-2788.
19. Kirshner J, Chen CJ, Liu P, Huang J, Shively JE, (2003) CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc Natl Acad Sci U S A 100: 521-526.
20. Chen CJ, Kirshner J, Sherman MA, Hu W, Nguyen T, et al. (2007) Mutation analysis of the short cytoplasmic domain of the cell-cell adhesion molecule CEACAM1 identifies residues that orchestrate actin binding and lumen formation. J Biol Chem 282: 5749-5760.
21. Yokoyama S, Chen CJ, Nguyen T, Shively JE, (2007) Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation. Oncogene 26: 7637-7646.
22. Cheung PH, Luo W, Qiu Y, Zhang X, Earley K, et al. (1993) Structure and function of C-CAM1. The first immunoglobulin domain is required for intercellular adhesion. J Biol Chem 268: 24303-24310.
23. Watt SM, Teixeira AM, Zhou GQ, Doyonnas R, Zhang Y, et al. (2001) Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site. Blood 98: 1469-1479.
24. Comegys MM, Lin SH, Rand D, Britt D, Flanagan D, et al. (2004) Two variable regions in carcinoembryonic antigen-related cell adhesion molecule1 N-terminal domains located in or next to monoclonal antibody and adhesion epitopes show evidence of recombination in rat but not in human. J Biol Chem 279: 35063-35078.
25. Zimmerman W, (1998) The Nature and Expression of the Rodent CEA Families: Evolutionary Considerations. In: Stanners CP, editors. Cell Adhesion and Communication Mediated by the CEA Family Singapore Hardwood Academic Publishers pp. 31-56.
26. Zebhauser R, Kammerer R, Eisenried A, McLellan A, Moore T, et al. (2005) Identification of a novel group of evolutionarily conserved members within the rapidly diverging murine Cea family. Genomics 86: 566-580.
27. Tan K, Zelus BD, Meijers R, Liu JH, Bergelson JM, et al. (2002) Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family. EMBO J 21: 2076-2086.
28. Russ WP, Engelman DM, (2000) The GxxxG motif: a framework for transmembrane helix-helix association. J Mol Biol 296: 911-919.
29. Senes A, Gerstein M, Engelman DM, (2000) Statistical analysis of amino acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in association with beta-branched residues at neighboring positions. J Mol Biol 296: 921-936.
30. Overton MC, Chinault SL, Blumer KJ, (2003) Oligomerization, biogenesis, and signaling is promoted by a glycophorin A-like dimerization motif in transmembrane domain 1 of a yeast G protein-coupled receptor. J Biol Chem 278: 49369-49377.
31. Schneider D, Engelman DM, (2004) Involvement of transmembrane domain interactions in signal transduction by alpha/beta integrins. J Biol Chem 279: 9840-9846.
32. Kim JH, Rutan JA, Vilen BJ, (2007) The transmembrane tyrosine of micro-heavy chain is required for BCR destabilization and entry of antigen into clathrin-coated vesicles. Int Immunol 19: 1403-1412.
33. Mowery J, Hixson DC, (1991) Detection of cell-CAM 105 in the pericanalicular domain of the rat hepatocyte plasma membrane. Hepatology 13: 47-56.
34. Faris RA, Monfils BA, Dunsford HA, Hixson DC, (1991) Antigenic relationship between oval cells and a subpopulation of hepatic foci, nodules, and carcinomas induced by the "resistant hepatocyte" model system. Cancer Res 51: 1308-1317.
35. Becker FF, Wolman SR, Asofsky R, Sell S, (1975) Sequential analysis of transplantable hepatocellular carcinomas. Cancer Res 35: 3021-3026.
36. Baum O, Reutter W, Flanagan D, Callanan H, Lim YP, et al. (1995) Anti-peptide sera against cell-CAM 105 determine high molecular-mass variants of the long isoform in rat hepatocytes. Eur J Biochem 228: 316-322.
37. Hixson DC, Allison JP, Chesner JE, Leger MJ, Ridge LL, et al. (1983) Characterization of a family of glycoproteins associated with the bile canalicular membrane of normal hepatocytes but not expressed by two transplantable rat hepatocellular carcinomas. Cancer Res 43: 3874-3884.
38. Comegys MM, Carreiro MP, Brown JF, Mazzacua A, Flanagan DL, et al. (1999) C-CAM1 expression: differential effects on morphology, differentiation state and suppression of human PC-3 prostate carcinoma cells. Oncogene 18: 3261-3276.
39. Ikehara S, Pahwa RN, Fernandes G, Hansen CT, Good RA, (1984) Functional T cells in athymic nude mice. Proc Natl Acad Sci U S A 81: 886-888.
40. Habu S, Fukui H, Shimamura K, Kasai M, Nagai Y, et al. (1981) In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol 127: 34-38.
41. Biebermann H, Schoneberg T, Schulz A, Krause G, Gruters A, et al. (1998) A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB J 12: 1461-1471.
42. Brosig B, Langosch D, (1998) The dimerization motif of the glycophorin A transmembrane segment in membranes: importance of glycine residues. Protein Sci 7: 1052-1056.
43. Hunter I, Sawa H, Edlund M, Obrink B, (1996) Evidence for regulated dimerization of cell-cell adhesion molecule (C-CAM) in epithelial cells. Biochem J 320 (Pt 3): 847-853.
44. Schagger H, von Jagow G, (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199: 223-231.
45. Kleiger G, Eisenberg D, (2002) GXXXG and GXXXA motifs stabilize FAD and NAD(P)-binding Rossmann folds through C(alpha)-H.. O hydrogen bonds and van der waals interactions. J Mol Biol 323: 69-76.
46. Overton MC, Chinault SL, Blumer KJ, (2005) Oligomerization of G-protein-coupled receptors: lessons from the yeast Saccharomyces cerevisiae. Eukaryot Cell 4: 1963-1970.
47. Segalat L, (2007) Loss-of-function genetic diseases and the concept of pharmaceutical targets. Orphanet J Rare Dis 2: 30.
48. Blagosklonny MV, (2000) p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect. FASEB J 14: 1901-1907.
49. Zambetti GP, Levine AJ, (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB J 7: 855-865.
50. Bu Z, Engelman DM, (1999) A method for determining transmembrane helix association and orientation in detergent micelles using small angle x-ray scattering. Biophys J 77: 1064-1073.
51. Russ WP, Engelman DM, (1999) TOXCAT: a measure of transmembrane helix association in a biological membrane. Proc Natl Acad Sci U S A 96: 863-868.
52. Sal-Man N, Gerber D, Bloch I, Shai Y, (2007) Specificity in transmembrane helix-helix interactions mediated by aromatic residues. J Biol Chem 282: 19753-19761.
53. Gazit E, (2002) A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J 16: 77-83.
54. Stevens TL, Blum JH, Foy SP, Matsuuchi L, DeFranco AL, (1994) A mutation of the mu transmembrane that disrupts endoplasmic reticulum retention. Effects on association with accessory proteins and signal transduction. J Immunol 152: 4397-4406.
55. Small SJ, Shull GE, Santoni MJ, Akeson R, (1987) Identification of a cDNA clone that contains the complete coding sequence for a 140-kD rat NCAM polypeptide. J Cell Biol 105: 2335-2345.
56. Orzaez M, Perez-Paya E, Mingarro I, (2000) Influence of the C-terminus of the glycophorin A transmembrane fragment on the dimerization process. Protein Sci 9: 1246-1253.
57. Gerber D, Sal-Man N, Shai Y, (2004) Two motifs within a transmembrane domain, one for homodimerization and the other for heterodimerization. J Biol Chem 279: 21177-21182.
58. Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, et al. (1993) Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci U S A 90: 1746-1750.
59. Gomyo H, Arai Y, Tanigami A, Murakami Y, Hattori M, et al. (1999) A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2. Genomics 62: 139-146.
60. Sternberg MJ, Gullick WJ, (1990) A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization. Protein Eng 3: 245-248.